The microbiome in infectious disease and inflammation

Annual Review of Immunology

Volumn 30, Issue , 2012, Pages 759-795

  Honda, Kenya ^a   Littman, Dan R ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clostridium; Innate lymphoid cells; Intestinal microbiota; Segmented filamentous bacteria; Th17 cells; Treg cells

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 4; CD40 LIGAND; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN A; LINOLENIC ACID; MYELOID DIFFERENTIATION FACTOR 88; PEPTIDE YY; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 8; TRANSCRIPTION FACTOR FOXP3;

ADAPTIVE IMMUNITY; BACILLUS; BACTEROIDES; BIFIDOBACTERIUM; CITROBACTER; CLOSTRIDIUM; COMMENSALISM; CORYNEBACTERIUM; DIETARY INTAKE; ENTERITIS; ESCHERICHIA; EUBACTERIUM; FIRMICUTES; GAMMA DELTA T LYMPHOCYTE; GENOTYPE; HOST SUSCEPTIBILITY; HUMAN; INNATE IMMUNITY; INTESTINE EPITHELIUM; INTESTINE FLORA; KLEBSIELLA PNEUMONIAE; LACHNOSPIRACEAE; LACTOBACILLUS; LYMPHOID CELL; MICROBIAL DIVERSITY; MICROBIOME; NONHUMAN; PLASMA CELL; PREVOTELLA; PRIORITY JOURNAL; PROPIONIBACTERIUM; REVIEW; STAPHYLOCOCCUS; TH17 CELL; ULCERATIVE COLITIS;

ADAPTIVE IMMUNITY; ANIMALS; COMMUNICABLE DISEASES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; INFLAMMATION; INTESTINAL MUCOSA; LYMPHOCYTES; METAGENOME; SIGNAL TRANSDUCTION;

EID: 84859389254     PISSN: 07320582     EISSN: 15453278     Source Type: Book Series    
DOI: 10.1146/annurev-immunol-020711-074937     Document Type: Review

References (255)

1. Berg RD. 1996. The indigenous gastrointestinal microflora. Trends Microbiol. 4:430-35
2. Xu J, Gordon JI. 2003. Honor thy symbionts. Proc. Natl. Acad. Sci. USA 100:10452-59
3. Macpherson AJ, Harris NL. 2004. Interactions between commensal intestinal bacteria and the immune system. Nat. Rev. Immunol. 4:478-85
4. Bouskra D, Bŕezillon C, B́erardM, Werts C, Varona R, et al. 2008. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 456:507-10
5. Cash HL, Whitham CV, Behrendt CL, Hooper LV. 2006. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313:1126-30
6. Vaishnava S, Behrendt CL, Ismail AS, Eckmann L, Hooper LV. 2008. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc. Natl. Acad. Sci. USA 105:20858-63
7. Hooper LV, Macpherson AJ. 2010. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat. Rev. Immunol. 10:159-69
8. Lederberg J. 2000. Infectious history. Science 288:287-93
9. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, et al. 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59-65
10. Round JL, Mazmanian SK. 2009. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9:313-23
11. Hill DA, Artis D. 2010. Intestinal bacteria and the regulation of immune cell homeostasis. Annu. Rev. Immunol. 28:623-67
12. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, et al. 2006. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55:205-11
13. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. 2007. Molecularphylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. USA 104:13780-85
14. Peterson DA, Frank DN, Pace NR, Gordon JI. 2008. Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe 3:417-27
15. WuHJ, Ivanov II, Darce J, Hattori K, Shima T, et al. 2010. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32:815-27
16. Scher JU, Abramson SB. 2011. Themicrobiome and rheumatoid arthritis. Nat. Rev. Rheumatol. 7:569-78
17. Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. 2011. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 108(Suppl. 1):4615-22
18. Berer K, Mues M, Koutrolos M, Rasbi ZA, Boziki M, et al. 2011. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479:538-41
19. Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, et al. 2008. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455:1109-13
20. Kriegel MA, Sefik E, Hill JA, Wu HJ, Benoist C, Mathis D. 2011. Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 108:11548-53
21. Hong PY, Lee BW, Aw M, Shek LP, Yap GC, et al. 2010. Comparative analysis of fecal microbiota in infants with and without eczema. PLo S One 5:e9964
22. Nakayama J, Kobayashi T, Tanaka S, Korenori Y, Tateyama A, et al. 2011. Aberrant structures of fecal bacterial community in allergic infants profiled by 16S r RNA gene pyrosequencing. FEMS Immunol. Med. Microbiol. 63:397-406
23. Sansonetti PJ. 2004. War and peace at mucosal surfaces. Nat. Rev. Immunol. 4:953-64
24. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. 2004. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118:229-41
25. Peterson DA, McNulty NP, Guruge JL, Gordon JI. 2007. Ig A response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe 2:328-39
26. Colonna M. 2009. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 31:15-23
27. Spits H, Di Santo JP. 2011. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat. Immunol. 12:21-27
28. Littman DR, Rudensky AY. 2010. Th17 and regulatoryTcells in mediating and restraining inflammation. Cell 140:845-58
29. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, et al. 2010. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. USA 107:11971-75
30. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, et al. 2005. Diversity of the human intestinal microbial flora. Science 308:1635-38
31. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, et al. 2011. Enterotypes of the human gut microbiome. Nature 473:174-80
32. Spor A, Koren O, Ley R. 2011. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat. Rev. Microbiol. 9:279-90
33. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:1027-31
34. Turnbaugh PJ, HamadyM, Yatsunenko T, Cantarel BL, Duncan A, et al. 2009. A core gut microbiome in obese and lean twins. Nature 457:480-84
35. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, et al. 2010. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328:228-31
36. GarrettWS, LordGM, Punit S, Lugo-VillarinoG, Mazmanian SK, et al. 2007. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131:33-45
37. Elinav E, Strowig T, Kau AL, Henao-Mejia J, Thaiss CA, et al. 2011. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145:745-57
38. Turnbaugh PJ, Backhed F, Fulton L, Gordon JI. 2008. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3:213-23
39. Zhang C, Zhang M, Wang S, Han R, Cao Y, et al. 2010. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J. 4:232-41
40. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. 2006. Microbial ecology: human gut microbes associated with obesity. Nature 444:1022-23
41. Duncan SH, Belenguer A, Holtrop G, Johnstone AM, Flint HJ, Lobley GE. 2007. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrateproducing bacteria in feces. Appl. Environ. Microbiol. 73:1073-78
42. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, et al. 2011. Linking long-term dietary patterns with gut microbial enterotypes. Science 334:105-8
43. De Filippo C, Cavalieri D, Di PaolaM, Ramazzotti M, Poullet JB, et al. 2010. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. USA 107:14691-96
44. Sonnenburg JL, Xu J, Leip DD, Chen CH, Westover BP, et al. 2005. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 307:1955-59
45. Hehemann JH, Correc G, Barbeyron T, Helbert W, Czjzek M, Michel G. 2010. Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota. Nature 464:908-12
46. Maslowski KM, Mackay CR. 2011. Diet, gut microbiota and immune responses. Nat. Immunol. 12:5-9
47. Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, et al. 2007. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2:119-29
48. Stecher B, Robbiani R, Walker AW, Westendorf AM, BarthelM, et al. 2007. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLo S Biol. 5:2177-89
49. Ermann J, Garrett WS, Kuchroo J, Rourida K, Glickman JN, et al. 2011. Severity of innate immunemediated colitis is controlled by the cytokine deficiency-induced colitis susceptibility-1 (Cdcs1) locus. Proc. Natl. Acad. Sci. USA 108:7137-41
50. Garrett WS, Gallini CA, Yatsunenko T, Michaud M, DuBois A, et al. 2010. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 8:292-300
51. Veiga P, Gallini CA, Beal C, Michaud M, Delaney ML, et al. 2010. Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes. Proc. Natl. Acad. Sci. USA 107:18132-37
52. Cummings JH, MacfarlaneGT, Macfarlane S. 2003. Intestinal bacteria and ulcerative colitis. Curr. Issues Intest. Microbiol. 4:9-20
53. Darfeuille-MichaudA, Boudeau J, Bulois P, Neut C, GlasserAL, et al. 2004. High prevalence of adherentinvasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127:412-21
54. Barnich N, Carvalho FA, Glasser AL, Darcha C, Jantscheff P, et al. 2007. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J. Clin. Investig. 117:1566-74
55. Collins MD, Lawson PA, Willems A, Cordoba JJ, Fernandez-Garayzabal J, et al. 1994. The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations. Int. J. Syst. Bacteriol. 44:812-26
56. Willing B, Halfvarson J, Dicksved J, Rosenquist M, Jarnerot G, et al. 2009. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm. Bowel Dis. 15:653-60
57. Sokol H, Seksik P, Rigottier-Gois L, Lay C, Lepage P, et al. 2006. Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm. Bowel Dis. 12:106-11
58. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Berḿudez- Humaŕan LG, et al. 2008. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. USA 105:16731-36
59. Fagarasan S, Muramatsu M, Suzuki K, Nagaoka H, Hiai H, Honjo T. 2002. Critical roles of activationinduced cytidine deaminase in the homeostasis of gut flora. Science 298:1424-27
60. Salzman NH, Hung K, Haribhai D, Chu H, Karlsson-Sj ̈ oberg J, et al. 2010. Enteric defensins are essential regulators of intestinal microbial ecology. Nat. Immunol. 11:76-83
61. Franke A, Balschun T, Karlsen TH, Sventoraityte J, Nikolaus S, et al. 2008. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat. Genet. 40:1319-23
62. McGovernDP, Gardet A, Torkvist L, Goyette P, Essers J, et al. 2010. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat. Genet. 42:332-37
63. Johansson ME, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. 2008. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc. Natl. Acad. Sci. USA 105:15064-69
64. Turner JR. 2009. Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 9:799-809
65. Slack E, Hapfelmeier S, Stecher B, Velykoredko Y, Stoel M, et al. 2009. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 325:617-20
66. Araki A, Kanai T, Ishikura T, Makita S, Uraushihara K, et al. 2005. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J. Gastroenterol. 40:16-23
67. Vijay-Kumar M, Sanders CJ, Taylor RT, Kumar A, Aitken JD, et al. 2007. Deletion of TLR5 results in spontaneous colitis in mice. J. Clin. Investig. 117:3909-21
68. Cario E, Gerken G, Podolsky DK. 2007. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132:1359-74
69. Podolsky DK, Gerken G, Eyking A, Cario E. 2009. Colitis-associated variant of TLR2 causes impaired mucosal repair because of TFF3 deficiency. Gastroenterology 137:209-20
70. Gibson DL, Ma C, Rosenberger CM, Bergstrom KS, Valdez Y, et al. 2008. Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis. Cell Microbiol. 10:388-403
71. Sonnenburg JL, Chen CT, Gordon JI. 2006. Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host. PLo S Biol. 4:e413
72. Brandl K, Plitas G, Mihu CN, Ubeda C, Jia T, et al. 2008. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 455:804-7
73. Kinnebrew MA, Ubeda C, Zenewicz LA, Smith N, Flavell RA, Pamer EG. 2010. Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection. J. Infect. Dis. 201:534-43
74. Cerutti A. 2008. The regulation of Ig A class switching. Nat. Rev. Immunol. 8:421-34
75. Tezuka H, Abe Y, Iwata M, Takeuchi H, Ishikawa H, et al. 2007. Regulation of Ig A production by naturally occurring TNF/iNOS-producing dendritic cells. Nature 448:929-33
76. Uematsu S, Fujimoto K, Jang MH, Yang BG, Jung YJ, et al. 2008. Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat. Immunol. 9:769-76
77. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. 2008. Autophagy fights disease through cellular self-digestion. Nature 451:1069-75
78. Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, et al. 2007. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 39:207-11
79. Prescott NJ, Fisher SA, Franke A, Hampe J, OnnieCM, et al. 2007. A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5. Gastroenterology 132:1665-71
80. Cadwell K, Liu JY, Brown SL, MiyoshiH, Loh J, et al. 2008. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456:259-63
81. Cadwell K, Patel KK, Maloney NS, Liu TC, Ng AC, et al. 2010. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 141:1135-45
82. Deretic V, Levine B. 2009. Autophagy, immunity, and microbial adaptations. Cell HostMicrobe 5:527-49
83. Shi CS, Kehrl JH. 2008. MyD88 and Trif target Beclin 1 to trigger autophagy in macrophages. J. Biol. Chem. 283:33175-82
84. Saitoh T, Fujita N, Jang MH, Uematsu S, Yang BG, et al. 2008. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1βproduction. Nature 456:264-68
85. Clayburgh DR, Musch MW, Leitges M, Fu YX, Turner JR. 2006. Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for TNF-mediated diarrhea in vivo. J. Clin. Investig. 116:2682-94
86. BooneDL, Turer EE, Lee EG, Ahmad RC, Wheeler MT, et al. 2004. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat. Immunol. 5:1052-60
87. Turer EE, Tavares RM, Mortier E, Hitotsumatsu O, Advincula R, et al. 2008. Homeostatic MyD88-dependent signals cause lethal inflammation in the absence of A20. J. Exp. Med. 205:451-64
88. Wald D, Qin J, Zhao Z, Qian Y, Naramura M, et al. 2003. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 4:920-27
89. Xiao H, GulenMF, Qin J, Yao J, Bulek K, et al. 2007. The Toll-interleukin-1 receptormember SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity 26:461-75
90. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263-74
91. Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, et al. 1999. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10:39-49
92. Kobayashi M, Kweon MN, Kuwata H, Schreiber RD, Kiyono H, et al. 2003. Toll-like receptordependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice. J. Clin. Investig. 111:1297-308
93. Rakoff-Nahoum S, Hao L, Medzhitov R. 2006. Role of Toll-like receptors in spontaneous commensaldependent colitis. Immunity 25:319-29
94. Liew FY, Xu D, Brint EK, O'Neill LA. 2005. Negative regulation of Toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5:446-58
95. Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, et al. 2007. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446:557-61
96. Zaph C, Troy AE, Taylor BC, Berman-Booty LD, Guild KJ, et al. 2007. Epithelial-cell-intrinsic IKK-β expression regulates intestinal immune homeostasis. Nature 446:552-56
97. Welz PS, Wullaert A, Vlantis K, Kondylis V, Ferńandez-Majada V, et al. 2011. FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 477:330-34
98. Inohara N, Chamaillard M, McDonald C, Nũ nez G. 2005. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu. Rev. Biochem. 74:355-83
99. Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, et al. 2005. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307:731-34
100. Petnicki-Ocwieja T, Hrncir T, Liu YJ, Biswas A, Hudcovic T, et al. 2009. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc. Natl. Acad. Sci. USA 106:15813-18
101. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, et al. 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411:603-6
102. Hugot JP, ChamaillardM, Zouali H, Lesage S, Cezard JP, et al. 2001. Association ofNOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411:599-603
103. vanHeel DA, Ghosh S, ButlerM, HuntKA, Lundberg AM, et al. 2005. Muramyl dipeptide andToll-like receptor sensitivity in NOD2-associated Crohn's disease. Lancet 365:1794-96
104. Carneiro LA, Magalhaes JG, Tattoli I, Philpott DJ, Travassos LH. 2008. Nod-like proteins in inflammation and disease. J. Pathol. 214:136-48
105. StroberW, Kitani A, Fuss I, Asano N, Watanabe T. 2008. The molecular basis of NOD2 susceptibility mutations in Crohn's disease. Mucosal Immunol. 1(Suppl. 1):S5-9
106. Girardin SE, Tournebize R, Mavris M, Page AL, Li X, et al. 2001. CARD4/Nod1 mediates NF-κB and JNK activation by invasive Shigella flexneri. EMBO Rep. 2:736-42
107. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, et al. 2004. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 5:1166-74
108. Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN. 2010. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat. Med. 16:228-31
109. Macfarlane S, Macfarlane GT. 2003. Regulation of short-chain fatty acid production. Proc. Nutr. Soc. 62:67-72
110. Scheppach W, Sommer H, Kirchner T, Paganelli GM, Bartram P, et al. 1992. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 103:51-56
111. Vernia P, Annese V, Bresci G, d'Albasio G, D'Inc̀a R, et al. 2003. Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial. Eur. J. Clin. Investig. 33:244-48
112. +-coupled transporter for short-chain fatty acids. J. Biol. Chem. 279:13293-96
113. Thibault R, Blachier F, Darcy-Vrillon B, deCoppet P, Bourreille A, Segain JP. 2010. Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency. Inflamm. Bowel Dis. 16:684-95
114. Thangaraju M, Cresci GA, Liu K, Ananth S, Gnanaprakasam JP, et al. 2009. GPR109A is a G-proteincoupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res. 69:2826-32
115. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, et al. 2003. The Orphan G proteincoupled receptorsGPR41 andGPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278:11312-19
116. Briscoe CP, Tadayyon M, Andrews JL, BensonWG, Chambers JK, et al. 2003. The orphan G proteincoupled receptor GPR40 is activated by medium and long chain fatty acids. J. Biol. Chem. 278:11303-11
117. Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, et al. 2005. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat. Med. 11:90-94
118. Ichimura A, Hirasawa A, Hara T, Tsujimoto G. 2009. Free fatty acid receptors act as nutrient sensors to regulate energy homeostasis. Prostaglandins Other Lipid Mediat. 89:82-88
119. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, et al. 2010. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142:687-98
120. Samuel BS, Shaito A, Motoike T, Rey FE, Backhed F, et al. 2008. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc. Natl. Acad. Sci. USA 105:16767-72
121. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, et al. 2009. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461:1282-86
122. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, et al. 2011. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469:543-47
123. Macpherson AJ, Gatto D, Sainsbury E, Harriman GR, Hengartner H, Zinkernagel RM. 2000. A primitive T cell-independent mechanism of intestinal mucosal Ig A responses to commensal bacteria. Science 288:2222-26
124. TsujiM, Suzuki K, Kitamura H, MaruyaM, Kinoshita K, et al. 2008. Requirement for lymphoid tissueinducer cells in isolated follicle formation and T cell-independent immunoglobulin A generation in the gut. Immunity 29:261-71
125. Cebra JJ. 1999. Influences of microbiota on intestinal immune system development. Am. J. Clin. Nutr. 69:S1046-51
126. Snel J, Bakker MH, Heidt PJ. 1997. Quantification of antigen-specific immunoglobulin A after oral booster immunization with ovalbumin in mice mono-associated with segmented filamentous bacteria or Clostridium innocuum. Immunol. Lett. 58:25-28
127. Talham GL, Jiang HQ, Bos NA, Cebra JJ. 1999. Segmented filamentous bacteria are potent stimuli of a physiologically normal state of the murine gut mucosal immune system. Infect. Immun. 67:1992-2000
128. Umesaki Y, Setoyama H, Matsumoto S, Imaoka A, ItohK. 1999. Differential roles of segmented filamentous bacteria and clostridia in development of the intestinal immune system. Infect. Immun. 67:3504-11
129. Caselli M, Holton J, Boldrini P, Vaira D, Calo G. 2010. Morphology of segmented filamentous bacteria and their patterns of contact with the follicle-associated epithelium of the mouse terminal ileum: implications for the relationship with the immune system. Gut Microbes 1:367-72
130. Mitsdoerffer M, Lee Y, Jager A, Kim HJ, Korn T, et al. 2010. Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc. Natl. Acad. Sci. USA 107:14292-97
131. Kolls JK, McCray PB Jr, Chan YR. 2008. Cytokine-mediated regulation of antimicrobial proteins. Nat. Rev. Immunol. 8:829-35
132. Mangan PR, Harrington LE, O'Quinn DB, HelmsWS, Bullard DC, et al. 2006. Transforming growth factor-βinduces development of the T(H)17 lineage. Nature 441:231-34
133. Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, et al. 2009. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J. Exp. Med. 206:299-311
134. Ishigame H, Kakuta S, Nagai T, Kadoki M, Nambu A, et al. 2009. Differential roles of interleukin-17A and-17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30:108-19
135. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, et al. 2006. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461-63
136. Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, et al. 2009. Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways. Nat. Genet. 41:199-204
137. Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, et al. 2010. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat. Genet. 42:508-14
138. + T helper cells. Cell 126:1121-33
139. Zhou L, Ivanov II, SpolskiR, Min R, Shenderov K, et al. 2007. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8:967-74
140. Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, et al. 2008. TGF-β-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORγt function. Nature 453:236-40
141. Li Y, Innocentin S, Withers DR, Roberts NA, Gallagher AR, et al. 2011. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 147:629-40
142. Veldhoen M, Hirota K, Christensen J, O'Garra A, Stockinger B. 2009. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. J. Exp. Med. 206:43-49
143. El-BehiM, Ciric B, Dai H, Yan Y, CullimoreM, et al. 2011. The encephalitogenicity of T(H)17 cells is dependent on IL-1-and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12:568-75
144. + lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 34:122-34
145. McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, et al. 2007. TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 8:1390-97
146. Chung Y, Chang SH, Martinez GJ, Yang XO, Nurieva R, et al. 2009. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30:576-87
147. MengG, Zhang F, Fuss I, KitaniA, StroberW. 2009. Amutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. Immunity 30:860-74
148. Manel N, Unutmaz D, Littman DR. 2008. The differentiation of human T(H)-17 cells requires transforming growth factor-βand induction of the nuclear receptor RORγt. Nat. Immunol. 9:641-49
149. Yang L, Anderson DE, Baecher-Allan C, Hastings WD, Bettelli E, et al. 2008. IL-21 and TGF-βare required for differentiation of human T(H)17 cells. Nature 454:350-52
150. Huh JR, Leung MW, Huang P, Ryan DA, Krout MR, et al. 2011. Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity. Nature 472:486-90
151. Atarashi K, Nishimura J, Shima T, Umesaki Y, Yamamoto M, et al. 2008. ATP drives lamina propria T(H)17 cell differentiation. Nature 455:808-12
152. Ivanov II, de Llanos Frutos R, Manel N, Yoshinaga K, Rifkin DB, et al. 2008. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4:337-49
153. Hall JA, Bouladoux N, Sun CM, Wohlfert EA, Blank RB, et al. 2008. CommensalDNAlimits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity 29:637-49
154. Kofoed EM, Vance RE. 2011. Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity. Nature 477:592-95
155. Zhao Y, Yang J, Shi J, Gong YN, Lu Q, et al. 2011. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 477:596-600
156. Torchinsky MB, Garaude J, Martin AP, Blander JM. 2009. Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation. Nature 458:78-82
157. Yoshida M, Claypool SM, Wagner JS, Mizoguchi E, Mizoguchi A, et al. 2004. Human neonatal Fc receptor mediates transport of Ig G into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity 20:769-83
158. Niess JH, Brand S, Gu X, Landsman L, Jung S, et al. 2005. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307:254-58
159. Travis MA, Reizis B, Melton AC, Masteller E, Tang Q, et al. 2007. Loss of integrin α(v)β8 on dendritic cells causes autoimmunity and colitis in mice. Nature 449:361-65
160. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, et al. 2009. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485-98
161. Gaboriau-Routhiau V, Rakotobe S, Lecuyer E, Mulder I, Lan A, et al. 2009. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31:677-89
162. Hirota K, Duarte JH, Veldhoen M, Hornsby E, Li Y, et al. 2011. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12:255-63
163. Yamauchi KE, Snel J. 2000. Transmission electron microscopic demonstration of phagocytosis and intracellular processing of segmented filamentous bacteria by intestinal epithelial cells of the chick ileum. Infect. Immun. 68:6496-504
164. Umesaki Y, Okada Y, Matsumoto S, Imaoka A, Setoyama H. 1995. Segmented filamentous bacteria are indigenous intestinal bacteria that activate intraepithelial lymphocytes and induce MHC class II molecules and fucosyl asialo GM1 glycolipids on the small intestinal epithelial cells in the ex-germ-free mouse. Microbiol. Immunol. 39:555-62
165. Shima T, Fukushima K, Setoyama H, Imaoka A, Matsumoto S, et al. 2008. Differential effects of two probiotic strains with different bacteriological properties on intestinal gene expression, with special reference to indigenous bacteria. FEMS Immunol. Med. Microbiol. 52:69-77
166. Heczko U, Abe A, Finlay BB. 2000. Segmented filamentous bacteria prevent colonization of enteropathogenic Escherichia coli O103 in rabbits. J. Infect. Dis. 181:1027-33
167. Sears CL, Islam S, Saha A, Arjumand M, Alam NH, et al. 2008. Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea. Clin. Infect. Dis. 47:797-803
168. Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, et al. 2009. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15:1016-22
169. Esplugues E, Huber S, Gagliani N, Hauser AE, Town T, et al. 2011. Control of TH17 cells occurs in the small intestine. Nature 475:514-18
170. Lochner M, Berard M, Sawa S, Hauer S, Gaboriau-Routhiau V, et al. 2011. Restricted microbiota and absence of cognate TCR antigen leads to an unbalanced generation of Th17 cells. J. Immunol. 186:1531-37
171. Lathrop SK, Bloom SM, Rao SM, Nutsch K, Lio CW, et al. 2011. Peripheral education of the immune system by colonic commensal microbiota. Nature 478:250-54
172. Marks BR, Nowyhed HN, Choi JY, Poholek AC, Odegard JM, et al. 2009. Thymic self-reactivity selects natural interleukin 17-producingTcells that can regulate peripheral inflammation. Nat. Immunol. 10:1125-32
173. Kim JS, Smith-Garvin JE, Koretzky GA, Jordan MS. 2011. The requirements for natural Th17 cell development are distinct from those of conventional Th17 cells. J. Exp. Med. 208:2201-7
174. van Wijk F, Cheroutre H. 2009. Intestinal T cells: facing the mucosal immune dilemma with synergy and diversity. Semin. Immunol. 21:130-38
175. +CD8ααT cells in the intestinal epithelial layer in the prevention of inflammatory bowel disease. Proc. Natl. Acad. Sci. USA 100:5324-29
176. Leishman AJ, Naidenko OV, Attinger A, Koning F, Lena CJ, et al. 2001. T cell responses modulated through interaction between CD8αand the nonclassicalMHCclass I molecule, TL. Science 294:1936-39
177. +CD8αα intraepithelial lymphocytes express genes that down-regulate their antigen reactivity and suppress immune responses. J. Immunol. 178:4230-39
178. Poussier P, Ning T, Banerjee D, Julius M. 2002. A unique subset of self-specific intraintestinal T cells maintains gut integrity. J. Exp. Med. 195:1491-97
179. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, et al. 1999. Activation ofNKcells andTcells by NKG2D, a receptor for stress-inducible MICA. Science 285:727-29
180. Boismenu R, Havran WL. 1994. Modulation of epithelial cell growth by intraepithelial γδTcells. Science 266:1253-55
181. Ismail AS, Severson KM, Vaishnava S, Behrendt CL, Yu X, et al. 2011. γδ intraepithelial lymphocytes are essential mediators of host-microbial homeostasis at the intestinal mucosal surface. Proc. Natl. Acad. Sci. USA 108:8743-48
182. Bandeira A, Mota-Santos T, Itohara S, Degermann S, Heusser C, et al. 1990. Localization of γ/δT cells to the intestinal epithelium is independent of normal microbial colonization. J. Exp. Med. 172:239-44
183. Martin B, Hirota K, Cua DJ, Stockinger B, Veldhoen M. 2009. Interleukin-17-producing γδ T cells selectively expand in response to pathogen products and environmental signals. Immunity 31:321-30
184. Lockhart E, Green AM, Flynn JL. 2006. IL-17 production is dominated by γδT cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 177:4662-69
185. + γδT cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J. Immunol. 178:4466-72
186. Awasthi A, Riol-Blanco L, Jager A, Korn T, Pot C, et al. 2009. Cutting edge: IL-23 receptor GFP reporter mice reveal distinct populations of IL-17-producing cells. J. Immunol. 182:5904-8
187. Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KH. 2009. Interleukin-1 and IL-23 induce innate IL-17 production from γδ T cells, amplifying Th17 responses and autoimmunity. Immunity 31:331-41
188. Duan J, Chung H, Troy E, Kasper DL. 2010. Microbial colonization drives expansion of IL-1 receptor 1-expressing and IL-17-producing γ/δT cells. Cell Host Microbe 7:140-50
189. Ito Y, Usui T, Kobayashi S, Iguchi-Hashimoto M, Ito H, et al. 2009. γ/δ T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis. Arthritis Rheum. 60:2294-303
190. Petermann F, Rothhammer V, Claussen MC, Haas JD, Blanco LR, et al. 2010. γδ T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. Immunity 33:351-63
191. Cua DJ, Tato CM. 2010. Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 10:479-89
192. + cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7:493-504
193. Eberl G, Marmon S, Sunshine MJ, Rennert PD, Choi Y, Littman DR. 2004. An essential function for the nuclear receptor RORγ(t) in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 5:64-73
194. Ivanov II, Diehl GE, Littman DR. 2006. Lymphoid tissue inducer cells in intestinal immunity. Curr. Top. Microbiol. Immunol. 308:59-82
195. + natural killer-like cells. Nat. Immunol. 10:66-74
196. Honda K, Nakano H, Yoshida H, Nishikawa S, Rennert P, et al. 2001. Molecular basis for hematopoietic/mesenchymal interaction during initiation of Peyer's patch organogenesis. J. Exp. Med. 193:621-30
197. + cells. Science 305:248-51
198. + innate lymphoid cells. Science 330:665-69
199. +CD3 accessory cells costimulate primedCD4Tcells throughOX40andCD30at sites whereTcells collaborate with B cells. Immunity 18:643-54
200. + innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat. Immunol. 12:320-26
201. + cells that provide innate mucosal immune defense. Immunity 29:958-70
202. + cells. Nat. Immunol. 10:83-91
203. + cell populations in gut and skin. Nat. Immunol. 10:75-82
204. Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Stevens S, Flavell RA. 2008. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29:947-57
205. Uhlig HH, McKenzie BS, Hue S, Thompson C, Joyce-Shaikh B, et al. 2006. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25:309-18
206. Hue S, Ahern P, Buonocore S, Kullberg MC, Cua DJ, et al. 2006. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J. Exp. Med. 203:2473-83
207. Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, et al. 2010. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464:1371-75
208. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. 2008. Regulatory T cells and immune tolerance. Cell 133:775-87
209. Izcue A, Coombes JL, Powrie F. 2006. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol. Rev. 212:256-71
210. Barnes MJ, Powrie F. 2009. Regulatory T cells reinforce intestinal homeostasis. Immunity 31:401-11
211. + T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197:111-19
212. Zheng Y, Rudensky AY. 2007. Foxp3 in control of the regulatory T cell lineage. Nat. Immunol. 8:457-62
213. + natural regulatoryTcells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl. Acad. Sci. USA 105:10113-18
214. Griseri T, Asquith M, Thompson C, Powrie F. 2010. OX40 is required for regulatory T cell-mediated control of colitis. J. Exp. Med. 207:699-709
215. Koch MA, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, Campbell DJ. 2009. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10:595-602
216. Zheng Y, Chaudhry A, Kas A, deRoos P, Kim JM, et al. 2009. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458:351-56
217. + regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326:986-91
218. + T cells in gut Peyer's patches. Science 323:1488-92
219. + regulatory T cells by peripheral expansion. J. Immunol. 173:7259-68
220. + regulatory T cells by TGF-βinduction of transcription factor Foxp3. J. Exp. Med. 198:1875-86
221. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, et al. 2007. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317:256-60
222. + regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J. Exp. Med. 204:1757-64
223. SunCM, Hall JA, Blank RB, Bouladoux N, Oukka M, et al. 2007. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204:1775-85
224. + regulatory T cell-dependent and-independent control of allergic inflammation. Immunity 29:114-26
225. + T regulatory cells. J. Immunol. 184:3433-41
226. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, et al. 2011. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331:337-41
227. Geuking MB, Cahenzli J, Lawson MA, Ng DC, Slack E, et al. 2011. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity 34:794-806
228. Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schaffer AA, Noyan F, et al. 2009. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med. 361:2033-45
229. Kamanaka M, Kim ST, Wan YY, Sutterwala FS, Lara-Tejero M, et al. 2006. Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. Immunity 25:941-52
230. - precursor cells in the absence of interleukin 10 Nat. Immunol. 8:931-41
231. Roers A, Siewe L, Strittmatter E, Deckert M, Schluter D, et al. 2004. T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. J. Exp. Med. 200:1289-97
232. Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, et al. 2008. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28:546-58
233. Park SG, Mathur R, Long M, Hosh N, Hao L, et al. 2010. T regulatory cells maintain intestinal homeostasis by suppressing γδT cells. Immunity 33:791-803
234. + T cells in an interleukin-10- dependent manner. Immunity 34:554-65
235. Chaudhry A, Samstein RM, Treuting P, Liang Y, Pils MC, et al. 2011. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34:566-78
236. Pot C, Jin H, Awasthi A, Liu SM, Lai CY, et al. 2009. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J. Immunol. 183:797-801
237. Apetoh L, Quintana FJ, Pot C, Joller N, Xiao S, et al. 2010. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat. Immunol. 11:854-61
238. Cretney E, Xin A, Shi W, Minnich M, Masson F, et al. 2011. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat. Immunol. 12:304-11
239. + dendritic cells in the regulation of tissue-selective T cell homing. J. Exp. Med. 202:1063-73
240. Denning TL, Wang YC, Patel SR, Williams IR, Pulendran B. 2007. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat. Immunol. 8:1086-94
241. Manicassamy S, Reizis B, Ravindran R, Nakaya H, Salazar-Gonzalez RM, et al. 2010. Activation of β-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science 329:849-53
242. DePaolo RW, Abadie V, Tang F, Fehlner-Peach H, Hall JA, et al. 2011. Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature 471:220-24
243. Di Giacinto C, Marinaro M, SanchezM, StroberW, Boirivant M. 2005. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-β-bearing regulatory cells. J. Immunol. 174:3237-46
244. Karimi K, Inman MD, Bienenstock J, Forsythe P. 2009. Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am. J. Respir. Crit. CareMed. 179:186-93
245. Livingston M, Loach D, Wilson M, Tannock GW, Baird M. 2009. Gut commensal Lactobacillus reuteri 100-23 stimulates an immunoregulatory response. Immunol. Cell Biol. 88:99-102
246. Torii A, Torii S, Fujiwara S, Tanaka H, Inagaki N, Nagai H. 2007. Lactobacillus acidophilus strain L-92 regulates the production of Th1 cytokine as well as Th2 cytokines. Allergol. Int. 56:293-301
247. Foligne B, Zoumpopoulou G, Dewulf J, Ben Younes A, Chareyre F, et al. 2007. A key role of dendritic cells in probiotic functionality. PLo S One 2:e313
248. Forsythe P, Inman MD, Bienenstock J. 2007. Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. Am. J. Respir. Crit. CareMed. 175:561-69
249. O'Mahony C, Scully P, O'Mahony D, Murphy S, O'Brien F, et al. 2008. Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-κB activation. PLo S Pathog. 4:e1000112
250. + regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. USA 107:12204-9
251. Mazmanian SK, Round JL, Kasper DL. 2008. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453:620-25
252. Round JL, Lee SM, Li J, Tran G, Jabri B, et al. 2011. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332:974-77
253. D'Angelo M, Billings PC, Pacifici M, Leboy PS, Kirsch T. 2001. Authenticmatrix vesicles contain active metalloproteases (MMP). a role for matrix vesicle-associated MMP-13 in activation of transforming growth factor-β. J. Biol. Chem. 276:11347-53
254. + dendritic cells express indoleamine 2, 3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction. Gut 59:595-604
255. Bloom SM, Bijanki VN, Nava GM, Sun L, Malvin NP, et al. 2011. Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe 9:390-403